About Dedham Group
Dedham Group is a Healthcare company based in New York (United States) founded in 2010, and was acquired by MMIT Network in April 2021. Market access strategic consulting is provided for the biopharma sector. The company has 46 employees. Dedham Group offers products and services including Strategy Consulting, Syndicated Reports, and PULSE Analytics. Its focus areas include Biopharma Outsourcing, Consulting, Business and Market Access & HEOR. Its competitors include Target RWE, Secura Bio and Hylant; 1 of its 3 listed competitors has raised funding.
Company details
The Dedham Group was founded in 2010 and is headquartered in New York, United States. Consulting services focused on market access strategies are delivered to clients in the biopharma industry. Operations emphasize advisory support for navigating regulatory and commercial challenges in pharmaceutical markets. Expertise is applied across various stages of product lifecycle management within the sector.
- Headquarters New York, United States
- Employees 46
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dedhamgroup.com
- Social LinkedIn X
- Acquired by MMIT Network (Apr 2021)
- Investors
- Employee Count46
- Acquired byMMIT Network
(Apr 2021)
Products & Services of Dedham Group
Dedham Group offers a comprehensive portfolio of products and services, including Strategy Consulting, Syndicated Reports, and PULSE Analytics.
Delivers strategic advice for market access and commercial planning
Provides market insights and data reports for biopharma stakeholders
Offers analytics tools for forecasting and business development
Investors in Dedham Group
Dedham Group has secured backing from 1 investor. Prominent investors backing the company include MMIT Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offers formulary data & analytics for market research, medication decision & formulary management | 1994 | mmitnetwork.com | Yardley, United States |
Investor details for Dedham Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dedham Group
1 people are tracked at Dedham Group (1 in leadership); the tracked headcount is 46.
| Name | Role | Group |
|---|---|---|
David Sauchelli | VP, Business Operations | Leadership |
Complete people profiles for Dedham Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dedham Group
2 dated milestones of Dedham Group across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Dedham Group is founded.
- Exit Acquired by MMIT Network.
Competitors of Dedham Group
Dedham Group has 3 listed competitors in our database, 1 of them funded. They include Target RWE, Secura Bio and Hylant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| targetrwe.com | 2017 | Durham, United States | 116 | Marketing services to the pharmaceutical industry are provided. | ||
| securabio.com | 2018 | Henderson, United States | $55M | Consulting services for market access and health outcomes are provided. | ||
| hylant.com | 1935 | Toledo, United States | 849 | Offers business insurance, employee benefits, and risk consulting services worldwide. |
Detailed competitors of Dedham Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Dedham Group
The website of Dedham Group (dedhamgroup.com) receives about 9.8K visits a month.
- Monthly visits9.8K
▲ 61.9% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Dedham Group (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dedham Group
Complete news archive for Dedham Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dedham Group
Dedham Group was founded in 2010.
Dedham Group is headquartered in New York, United States. It is registered at New York, New York, United States.
Dedham Group has 46 employees.
The Dedham Group was founded in 2010 and is headquartered in New York, United States. Consulting services focused on market access strategies are delivered to clients in the biopharma industry. Operations emphasize advisory support for navigating regulatory and commercial challenges in pharmaceutical markets. Expertise is applied across various stages of product lifecycle management within the sector.
Dedham Group's top competitors include Target RWE, Secura Bio and Hylant.
Dedham Group offers Strategy Consulting, Syndicated Reports, and PULSE Analytics.
Dedham Group has 1 investor. Key investors include MMIT Network.
Yes. Dedham Group was acquired by MMIT Network in April 2021.